[SCHEDULE 13G] Safety Shot, Inc. Warrant SEC Filing

Rhea-AI Filing Summary

On 30 Jul 2025, an investor group headed by American Ventures LLC, Series XII SHOT filed a Schedule 13G reporting ownership of 10,835,141 Safety Shot, Inc. (SHOT) common shares, equal to 8.95 % of the 121,048,833 shares outstanding (as of 21 Jul 2025). All voting and dispositive power is shared among six affiliated reporting persons: American Ventures Management LLC, American Ventures IM LLC, Dominari Holdings Inc., and individuals Eric Newman, Kyle Michael Wool and Anthony Hayes; none holds sole power.

The group also holds two tranches of warrants—Series A and Series B—each exercisable for up to 10,835,141 additional shares. These warrants are currently excluded from beneficial-ownership calculations because 4.99 % (optionally 9.99 %) “blockers” prevent exercise within 60 days. Full exercise would add 21.7 M shares, potentially raising the group’s stake toward 27 % and creating a significant dilution overhang.

The filing is marked “passive,” stating the securities were not acquired to influence control of the issuer. No purchase price, funding terms or board arrangements are disclosed.

Positive

• Significant outside interest: a sophisticated investor group is willing to hold nearly 9 % of SHOT’s equity, which can be interpreted as confidence in the company’s prospects.

Negative

• Potential dilution risk: two warrant series could add 21.7 M shares (≈18 % of current float) if exercised.
• Share overhang: the group’s large stake, combined with unexercised warrants, may cap near-term price appreciation if the market anticipates future sales or conversions.

Insights

Equity Analyst

TL;DR: 8.95 % passive stake disclosed; large unexercised warrants could be dilutive but are contractually blocked for now.

The appearance of a near-9 % holder is noteworthy yet neutral to valuation in the short term. Because voting/dispositive power is shared among multiple affiliated entities, the group lacks single-party control. The key risk is potential dilution: if both Series A and Series B warrants are ultimately exercised, the share count could rise by ~18 %. However, the 4.99 %/9.99 % blockers stagger potential exercises, reducing immediate pressure. Investors should monitor future 13D/G amendments for warrant conversions or stake changes.

Corporate Governance Specialist

TL;DR: Passive filing limits governance impact; ownership structure complex but lacks control intent.

Because the Schedule 13G (vs. 13D) signals no activist agenda, board dynamics remain unchanged. Shared ownership among LLCs and individuals diffuses influence, and the certification explicitly disclaims efforts to change control. Nevertheless, cumulative warrants give the group latent leverage that could become material if blockers are lifted. Governance watchers should track any switch to Schedule 13D, which would indicate a strategic shift.

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

Safety Shot, Inc.

(Name of Issuer)

Common Stock

(Title of Class of Securities)

48208F105

(CUSIP Number)

07/23/2025

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

SCHEDULE 13G

CUSIP No. 48208F105

1

Names of Reporting Persons

American Ventures LLC, Series XII SHOT

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

UNITED STATES

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 10,835,141.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 10,835,141.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

10,835,141.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

8.95 %

12

Type of Reporting Person (See Instructions)

OO

Comment for Type of Reporting Person: The number of shares represented by the amount in Rows 6, 8 and 9 excludes (i) 10,835,141 shares of common stock that may be purchased by exercising the Issuer's Series A Common Stock Purchase Warrants ("Series A Warrants") and (ii) 10,835,141 shares of common stock that may be purchased by exercising Series B Common Stock Purchase Warrants ("Series B Warrants"), neither of which are currently exercisable within 60 days. Pursuant to the warrant agreements relating to the Series A Warrants and the Series B Warrants, the Series A and Series B warrants are subject to 4.99% (or, at the election of the holder, 9.99%) beneficial ownership limitations or "blockers," wherein American Ventures LLC, Series XII SHOT ("Series XII SHOT") may not exercise its Series A and/or Series B warrants for shares of common stock to the extent that, upon giving effect to such exercise, Series XII SHOT together with its affiliates, and any other persons acting as a group together with Series XII SHOT or any of the Series XII SHOT's affiliates (such persons, "Attribution Parties") would beneficially own greater than 4.99% (or, at the election of Series XII SHOT, 9.99%) of the Issuer's common stock as calculated in accordance with Rule 13d-3 under the Securities Exchange Act of 1934, as amended. For purposes of the foregoing sentence, the number of shares of common stock beneficially owned by Series XII SHOT and its affiliates and Attribution Parties shall include the number of shares of common stock issuable upon exercise of the Series A and Series B Warrants with respect to which such determination is being made, but shall exclude the number of shares of common stock which would be issuable upon (i) exercise of the remaining, nonexercised portion of each such Warrant beneficially owned by Series XII SHOT or any of its Affiliates or Attribution Parties and (ii) exercise or conversion of the unexercised or nonconverted portion of any other securities of the Issuer (including, without limitation, any other common stock equivalents) subject to a limitation on conversion or exercise analogous to the limitation contained therein beneficially owned by Series XII SHOT or any of its affiliates or Attribution Parties. The aggregate number of shares of common stock and the percentage of total outstanding shares of common stock beneficially owned by the Reporting Persons gives effect to this beneficial ownership blocker. The percent of class represented by the amount in Row 9 is based on 121,048,833 shares of the Issuer's common stock issued and outstanding as of July 21, 2025, as reported in the Issuer's Prospectus Supplement filed with the SEC on July 23, 2025

SCHEDULE 13G

CUSIP No. 48208F105

1

Names of Reporting Persons

American Ventures Management LLC

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

UNITED STATES

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 10,835,141.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 10,835,141.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

10,835,141.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

8.95 %

12

Type of Reporting Person (See Instructions)

OO

Comment for Type of Reporting Person: The number of shares represented by the amount in Rows 6, 8 and 9 excludes (i) 10,835,141 shares of common stock that may be purchased by exercising the Issuer's Series A Common Stock Purchase Warrants ("Series A Warrants") and (ii) 10,835,141 shares of common stock that may be purchased by exercising Series B Common Stock Purchase Warrants ("Series B Warrants"), neither of which are currently exercisable within 60 days. Pursuant to the warrant agreements relating to the Series A Warrants and the Series B Warrants, the Series A and Series B warrants are subject to 4.99% (or, at the election of the holder, 9.99%) beneficial ownership limitations or "blockers," wherein American Ventures LLC, Series XII SHOT ("Series XII SHOT") may not exercise its Series A and/or Series B warrants for shares of common stock to the extent that, upon giving effect to such exercise, Series XII SHOT together with its affiliates, and any other persons acting as a group together with Series XII SHOT or any of the Series XII SHOT's affiliates (such persons, "Attribution Parties") would beneficially own greater than 4.99% (or, at the election of Series XII SHOT, 9.99%) of the Issuer's common stock as calculated in accordance with Rule 13d-3 under the Securities Exchange Act of 1934, as amended. For purposes of the foregoing sentence, the number of shares of common stock beneficially owned by Series XII SHOT and its affiliates and Attribution Parties shall include the number of shares of common stock issuable upon exercise of the Series A and Series B Warrants with respect to which such determination is being made, but shall exclude the number of shares of common stock which would be issuable upon (i) exercise of the remaining, nonexercised portion of each such Warrant beneficially owned by Series XII SHOT or any of its Affiliates or Attribution Parties and (ii) exercise or conversion of the unexercised or nonconverted portion of any other securities of the Issuer (including, without limitation, any other common stock equivalents) subject to a limitation on conversion or exercise analogous to the limitation contained therein beneficially owned by Series XII SHOT or any of its affiliates or Attribution Parties. The aggregate number of shares of common stock and the percentage of total outstanding shares of common stock beneficially owned by the Reporting Persons gives effect to this beneficial ownership blocker. The percent of class represented by the amount in Row 9 is based on 121,048,833 shares of the Issuer's common stock issued and outstanding as of July 21, 2025, as reported in the Issuer's Prospectus Supplement filed with the SEC on July 23, 2025.

SCHEDULE 13G

CUSIP No. 48208F105

1

Names of Reporting Persons

American Ventures IM LLC

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

UNITED STATES

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 10,835,141.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 10,835,141.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

10,835,141.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

8.95 %

12

Type of Reporting Person (See Instructions)

OO

Comment for Type of Reporting Person: The number of shares represented by the amount in Rows 6, 8 and 9 excludes (i) 10,835,141 shares of common stock that may be purchased by exercising the Issuer's Series A Common Stock Purchase Warrants ("Series A Warrants") and (ii) 10,835,141 shares of common stock that may be purchased by exercising Series B Common Stock Purchase Warrants ("Series B Warrants"), neither of which are currently exercisable within 60 days. Pursuant to the warrant agreements relating to the Series A Warrants and the Series B Warrants, the Series A and Series B warrants are subject to 4.99% (or, at the election of the holder, 9.99%) beneficial ownership limitations or "blockers," wherein American Ventures LLC, Series XII SHOT ("Series XII SHOT") may not exercise its Series A and/or Series B warrants for shares of common stock to the extent that, upon giving effect to such exercise, Series XII SHOT together with its affiliates, and any other persons acting as a group together with Series XII SHOT or any of the Series XII SHOT's affiliates (such persons, "Attribution Parties") would beneficially own greater than 4.99% (or, at the election of Series XII SHOT, 9.99%) of the Issuer's common stock as calculated in accordance with Rule 13d-3 under the Securities Exchange Act of 1934, as amended. For purposes of the foregoing sentence, the number of shares of common stock beneficially owned by Series XII SHOT and its affiliates and Attribution Parties shall include the number of shares of common stock issuable upon exercise of the Series A and Series B Warrants with respect to which such determination is being made, but shall exclude the number of shares of common stock which would be issuable upon (i) exercise of the remaining, nonexercised portion of each such Warrant beneficially owned by Series XII SHOT or any of its Affiliates or Attribution Parties and (ii) exercise or conversion of the unexercised or nonconverted portion of any other securities of the Issuer (including, without limitation, any other common stock equivalents) subject to a limitation on conversion or exercise analogous to the limitation contained therein beneficially owned by Series XII SHOT or any of its affiliates or Attribution Parties. The aggregate number of shares of common stock and the percentage of total outstanding shares of common stock beneficially owned by the Reporting Persons gives effect to this beneficial ownership blocker. The percent of class represented by the amount in Row 9 is based on 121,048,833 shares of the Issuer's common stock issued and outstanding as of July 21, 2025, as reported in the Issuer's Prospectus Supplement filed with the SEC on July 23, 2025.

SCHEDULE 13G

CUSIP No. 48208F105

1

Names of Reporting Persons

Dominari Holdings Inc.

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

UNITED STATES

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 10,835,141.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 10,835,141.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

10,835,141.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

8.95 %

12

Type of Reporting Person (See Instructions)

CO

Comment for Type of Reporting Person: The number of shares represented by the amount in Rows 6, 8 and 9 excludes (i) 10,835,141 shares of common stock that may be purchased by exercising the Issuer's Series A Common Stock Purchase Warrants ("Series A Warrants") and (ii) 10,835,141 shares of common stock that may be purchased by exercising Series B Common Stock Purchase Warrants ("Series B Warrants"), neither of which are currently exercisable within 60 days. Pursuant to the warrant agreements relating to the Series A Warrants and the Series B Warrants, the Series A and Series B warrants are subject to 4.99% (or, at the election of the holder, 9.99%) beneficial ownership limitations or "blockers," wherein American Ventures LLC, Series XII SHOT ("Series XII SHOT") may not exercise its Series A and/or Series B warrants for shares of common stock to the extent that, upon giving effect to such exercise, Series XII SHOT together with its affiliates, and any other persons acting as a group together with Series XII SHOT or any of the Series XII SHOT's affiliates (such persons, "Attribution Parties") would beneficially own greater than 4.99% (or, at the election of Series XII SHOT, 9.99%) of the Issuer's common stock as calculated in accordance with Rule 13d-3 under the Securities Exchange Act of 1934, as amended. For purposes of the foregoing sentence, the number of shares of common stock beneficially owned by Series XII SHOT and its affiliates and Attribution Parties shall include the number of shares of common stock issuable upon exercise of the Series A and Series B Warrants with respect to which such determination is being made, but shall exclude the number of shares of common stock which would be issuable upon (i) exercise of the remaining, nonexercised portion of each such Warrant beneficially owned by Series XII SHOT or any of its Affiliates or Attribution Parties and (ii) exercise or conversion of the unexercised or nonconverted portion of any other securities of the Issuer (including, without limitation, any other common stock equivalents) subject to a limitation on conversion or exercise analogous to the limitation contained therein beneficially owned by Series XII SHOT or any of its affiliates or Attribution Parties. The aggregate number of shares of common stock and the percentage of total outstanding shares of common stock beneficially owned by the Reporting Persons gives effect to this beneficial ownership blocker. The percent of class represented by the amount in Row 9 is based on 121,048,833 shares of the Issuer's common stock issued and outstanding as of July 21, 2025, as reported in the Issuer's Prospectus Supplement filed with the SEC on July 23, 2025.

SCHEDULE 13G

CUSIP No. 48208F105

1

Names of Reporting Persons

Eric Newman

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

UNITED STATES

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 10,835,141.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 10,835,141.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

10,835,141.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

8.95 %

12

Type of Reporting Person (See Instructions)

IN

Comment for Type of Reporting Person: The number of shares represented by the amount in Rows 6, 8 and 9 excludes (i) 10,835,141 shares of common stock that may be purchased by exercising the Issuer's Series A Common Stock Purchase Warrants ("Series A Warrants") and (ii) 10,835,141 shares of common stock that may be purchased by exercising Series B Common Stock Purchase Warrants ("Series B Warrants"), neither of which are currently exercisable within 60 days. Pursuant to the warrant agreements relating to the Series A Warrants and the Series B Warrants, the Series A and Series B warrants are subject to 4.99% (or, at the election of the holder, 9.99%) beneficial ownership limitations or "blockers," wherein American Ventures LLC, Series XII SHOT ("Series XII SHOT") may not exercise its Series A and/or Series B warrants for shares of common stock to the extent that, upon giving effect to such exercise, Series XII SHOT together with its affiliates, and any other persons acting as a group together with Series XII SHOT or any of the Series XII SHOT's affiliates (such persons, "Attribution Parties") would beneficially own greater than 4.99% (or, at the election of Series XII SHOT, 9.99%) of the Issuer's common stock as calculated in accordance with Rule 13d-3 under the Securities Exchange Act of 1934, as amended. For purposes of the foregoing sentence, the number of shares of common stock beneficially owned by Series XII SHOT and its affiliates and Attribution Parties shall include the number of shares of common stock issuable upon exercise of the Series A and Series B Warrants with respect to which such determination is being made, but shall exclude the number of shares of common stock which would be issuable upon (i) exercise of the remaining, nonexercised portion of each such Warrant beneficially owned by Series XII SHOT or any of its Affiliates or Attribution Parties and (ii) exercise or conversion of the unexercised or nonconverted portion of any other securities of the Issuer (including, without limitation, any other common stock equivalents) subject to a limitation on conversion or exercise analogous to the limitation contained therein beneficially owned by Series XII SHOT or any of its affiliates or Attribution Parties. The aggregate number of shares of common stock and the percentage of total outstanding shares of common stock beneficially owned by the Reporting Persons gives effect to this beneficial ownership blocker. The percent of class represented by the amount in Row 9 is based on 121,048,833 shares of the Issuer's common stock issued and outstanding as of July 21, 2025, as reported in the Issuer's Prospectus Supplement filed with the SEC on July 23, 2025.

SCHEDULE 13G

CUSIP No. 48208F105

1

Names of Reporting Persons

Anthony Hayes

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

UNITED STATES

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 10,835,141.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 10,835,141.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

10,835,141.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

8.95 %

12

Type of Reporting Person (See Instructions)

IN

Comment for Type of Reporting Person: The number of shares represented by the amount in Rows 6, 8 and 9 excludes (i) 10,835,141 shares of common stock that may be purchased by exercising the Issuer's Series A Common Stock Purchase Warrants ("Series A Warrants") and (ii) 10,835,141 shares of common stock that may be purchased by exercising Series B Common Stock Purchase Warrants ("Series B Warrants"), neither of which are currently exercisable within 60 days. Pursuant to the warrant agreements relating to the Series A Warrants and the Series B Warrants, the Series A and Series B warrants are subject to 4.99% (or, at the election of the holder, 9.99%) beneficial ownership limitations or "blockers," wherein American Ventures LLC, Series XII SHOT ("Series XII SHOT") may not exercise its Series A and/or Series B warrants for shares of common stock to the extent that, upon giving effect to such exercise, Series XII SHOT together with its affiliates, and any other persons acting as a group together with Series XII SHOT or any of the Series XII SHOT's affiliates (such persons, "Attribution Parties") would beneficially own greater than 4.99% (or, at the election of Series XII SHOT, 9.99%) of the Issuer's common stock as calculated in accordance with Rule 13d-3 under the Securities Exchange Act of 1934, as amended. For purposes of the foregoing sentence, the number of shares of common stock beneficially owned by Series XII SHOT and its affiliates and Attribution Parties shall include the number of shares of common stock issuable upon exercise of the Series A and Series B Warrants with respect to which such determination is being made, but shall exclude the number of shares of common stock which would be issuable upon (i) exercise of the remaining, nonexercised portion of each such Warrant beneficially owned by Series XII SHOT or any of its Affiliates or Attribution Parties and (ii) exercise or conversion of the unexercised or nonconverted portion of any other securities of the Issuer (including, without limitation, any other common stock equivalents) subject to a limitation on conversion or exercise analogous to the limitation contained therein beneficially owned by Series XII SHOT or any of its affiliates or Attribution Parties. The aggregate number of shares of common stock and the percentage of total outstanding shares of common stock beneficially owned by the Reporting Persons gives effect to this beneficial ownership blocker. The percent of class represented by the amount in Row 9 is based on 121,048,833 shares of the Issuer's common stock issued and outstanding as of July 21, 2025, as reported in the Issuer's Prospectus Supplement filed with the SEC on July 23, 2025.

SCHEDULE 13G

CUSIP No. 48208F105

1

Names of Reporting Persons

Kyle Michael Wool

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

UNITED STATES

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 10,835,141.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 10,835,141.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

10,835,141.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

8.95 %

12

Type of Reporting Person (See Instructions)

IN

Comment for Type of Reporting Person: The number of shares represented by the amount in Rows 6, 8 and 9 excludes (i) 10,835,141 shares of common stock that may be purchased by exercising the Issuer's Series A Common Stock Purchase Warrants ("Series A Warrants") and (ii) 10,835,141 shares of common stock that may be purchased by exercising Series B Common Stock Purchase Warrants ("Series B Warrants"), neither of which are currently exercisable within 60 days. Pursuant to the warrant agreements relating to the Series A Warrants and the Series B Warrants, the Series A and Series B warrants are subject to 4.99% (or, at the election of the holder, 9.99%) beneficial ownership limitations or "blockers," wherein American Ventures LLC, Series XII SHOT ("Series XII SHOT") may not exercise its Series A and/or Series B warrants for shares of common stock to the extent that, upon giving effect to such exercise, Series XII SHOT together with its affiliates, and any other persons acting as a group together with Series XII SHOT or any of the Series XII SHOT's affiliates (such persons, "Attribution Parties") would beneficially own greater than 4.99% (or, at the election of Series XII SHOT, 9.99%) of the Issuer's common stock as calculated in accordance with Rule 13d-3 under the Securities Exchange Act of 1934, as amended. For purposes of the foregoing sentence, the number of shares of common stock beneficially owned by Series XII SHOT and its affiliates and Attribution Parties shall include the number of shares of common stock issuable upon exercise of the Series A and Series B Warrants with respect to which such determination is being made, but shall exclude the number of shares of common stock which would be issuable upon (i) exercise of the remaining, nonexercised portion of each such Warrant beneficially owned by Series XII SHOT or any of its Affiliates or Attribution Parties and (ii) exercise or conversion of the unexercised or nonconverted portion of any other securities of the Issuer (including, without limitation, any other common stock equivalents) subject to a limitation on conversion or exercise analogous to the limitation contained therein beneficially owned by Series XII SHOT or any of its affiliates or Attribution Parties. The aggregate number of shares of common stock and the percentage of total outstanding shares of common stock beneficially owned by the Reporting Persons gives effect to this beneficial ownership blocker. The percent of class represented by the amount in Row 9 is based on 121,048,833 shares of the Issuer's common stock issued and outstanding as of July 21, 2025, as reported in the Issuer's Prospectus Supplement filed with the SEC on July 23, 2025. Additionally, the number of shares represented by the amount in Rows 6, 8 and 9 excludes 7,212 shares of the Issuer's Series B Preferred Stock held by Trajan Holdings LLC ("Trajan"), each share convertible into a number shares of common stock obtained by dividing the stated value of each such share of Series B Preferred Stock ($750) by the conversion price of $0.34. Mr. Wool is the sole member and manager of Trajan and thus has sole voting power and dispositive power over the securities of the Issuer held by Trajan. As a result, Mr. Wool may be deemed to indirectly beneficially own the securities held by Trajan. Mr. Wool disclaims beneficial ownership over any securities held by Trajan other than to the extent of his respective pecuniary interest therein, directly or indirectly.

SCHEDULE 13G

Item 1.
(a)	Name of issuer: Safety Shot, Inc.
(b)	Address of issuer's principal executive offices: 1061 E. Indiantown Rd., Suite 110, Jupiter, FL 33477
Item 2.
(a)	Name of person filing: American Ventures LLC, Series XII SHOT ("Series XII SHOT") owns the shares of the Issuer's common stock directly. American Ventures Management LLC ("AV Management") is the manager of Series XII SHOT. American Ventures IM LLC ("AV IM") is the investment manager of Series XII SHOT. Dominari Holdings Inc. ("DOMH") is the majority member of AV Management and AV IM that controls the voting power and dispositive power over securities of the Issuer held by entities managed or controlled by AV Management and/or AV IM. Eric Newman is the manager of both AV Management and AV IM. Kyle Michael Wool ("Mr. Wool") is the President and director of DOMH. Anthony Hayes ("Mr. Hayes") is the Chief Executive Officer, a director and Chairman of the board of directors of DOMH. AV Management, AV IM, DOMH, Mr. Newman, Mr. Wool and Mr. Hayes share voting and dispositive power over the securities held by Series XII SHOT. As a result, each of AV Management, AV IM, DOMH, Mr. Wool and Mr. Hayes may be deemed to indirectly beneficially own the securities held by the Series XII SHOT. Each of AV Management, AV IM, DOMH, Mr. Newman, Mr. Wool and Mr. Hayes disclaim beneficial ownership over any securities held by the Series XII SHOT other than to the extent of its/his respective pecuniary interest therein, directly or indirectly. AV Management, Series XII SHOT, AV IM, DOMH, Mr. Newman, Mr. Wool and Mr. Hayes are the reporting persons in this Schedule 13G (the "Reporting Persons").
(b)	Address or principal business office or, if none, residence: AV Management, Series XII SHOT, AV IM and Mr. Newman have a principal business office at 110 Front Street, Suite 300, Jupiter, Florida 33477. DOMH, Mr. Wool and Mr. Hayes have a principal business office at 725 Fifth Avenue, 22nd Floor, New York, New York 10022.
(c)	Citizenship: The Reporting Persons are citizens of the United States of America.
(d)	Title of class of securities: Common Stock
(e)	CUSIP No.: 48208F105
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: See the response to row 9 of the cover page of each Reporting Person.
(b)	Percent of class: See the response to row 11 of the cover page of each Reporting Person.
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: See the response to row 5 of the cover page of each Reporting Person.
	(ii) Shared power to vote or to direct the vote: See the response to row 6 of the cover page of each Reporting Person.
	(iii) Sole power to dispose or to direct the disposition of: See the response to row 7 of the cover page of each Reporting Person.
	(iv) Shared power to dispose or to direct the disposition of: See the response to row 8 of the cover page of each Reporting Person.
Item 5.	Ownership of 5 Percent or Less of a Class.
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	Not Applicable
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	Not Applicable
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

American Ventures LLC, Series XII SHOT

Signature:	/s/ Eric Newman
Name/Title:	Eric Newman, Manager of American Ventures Management LLC, Manager of American Ventures LLC, Series XII SHOT
Date:	07/30/2025

American Ventures Management LLC

Signature:	/s/ Eric Newman
Name/Title:	Eric Newman, Manager
Date:	07/30/2025

American Ventures IM LLC

Signature:	/s/ Eric Newman
Name/Title:	Eric Newman, Manager
Date:	07/30/2025

Dominari Holdings Inc.

Signature:	/s/ Kyle Michael Wool
Name/Title:	Kyle Michael Wool, President
Date:	07/30/2025

Eric Newman

Signature:	/s/ Eric Newman
Name/Title:	Eric Newman, Self
Date:	07/30/2025

Anthony Hayes

Signature:	/s/ Anthony Hayes
Name/Title:	Anthony Hayes, Self
Date:	07/30/2025

Kyle Michael Wool

Signature:	/s/ Kyle Michael Wool
Name/Title:	Kyle Michael Wool, Self
Date:	07/30/2025

Exhibit Information

99.1 Joint Filing Agreement

FAQ

How many Safety Shot (SHOT) shares does the reporting group own?

They report 10,835,141 common shares, representing 8.95 % of shares outstanding.

Who are the main entities behind American Ventures’ 13G filing?

American Ventures LLC Series XII SHOT, American Ventures Management LLC, American Ventures IM LLC, Dominari Holdings Inc., and individuals Eric Newman, Kyle Michael Wool, Anthony Hayes.

What is the significance of the Series A and Series B warrants?

Each warrant block covers 10,835,141 shares; they are not currently exercisable due to 4.99 %/9.99 % ownership blockers.

Does the filing indicate an activist or control intent?

No. The Schedule 13G is marked passive and includes a certification that the securities were not acquired to influence control.

When did the ownership threshold trigger this filing?

The reportable event date is 23 Jul 2025; the Schedule 13G was filed on 30 Jul 2025.